IDEXX Laboratories Inc (IDXX)

Industry Diagnostics & Research


This stock can be held in an Investment ISA and an Investment Account
Sell

$629.00

Buy

$699.00

arrow-up$2.42 (+0.35%)

Prices updated at 18 Dec 2025, 00:01 EST
| Prices minimum 15 mins delay
|
Prices in USD

IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets.

Income statement

20232024
3,661m3,898m
2,190m2,379m
1,097m1,128m
29.9728.95
845m888m
1,218m1,271m
Sales, General and administrative902m1,031m
Interest expenses42m31m
Provision for income taxes216m222m
Operating expenses1,093m1,251m
Income before taxes1,061m1,110m
Net income available to common shareholders845m888m
10.1710.77
Net interest income-36m-19m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)10.0610.67
Free cash flow per share8.09769.4816
Book value/share15.625419.8281
Debt equity ratio0.4867220.343269

Balance sheet

20232024
Current assets1,495m1,400m
Current liabilities952m1,068m
Total capital2,107m2,045m
Total debt1,067m987m
Total equity1,485m1,595m
Total non current liabilities--
Loans623m450m
Total assets3,260m3,293m
Total liabilities--
Cash and cash equivalents454m288m
Common stock83m82m

Cash flow

20232024
Cash at beginning of period113m454m
Cash dividends paid--
773m798m
Investments (gains) losses-125m-207m
454m288m
Net income--
907m929m
-134m-131m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.